AI & ChatGPT searches , social queriess for RIBOCICLIB
Search references for RIBOCICLIB. Phrases containing RIBOCICLIB
See searches and references containing RIBOCICLIB!
Search references for RIBOCICLIB. Phrases containing RIBOCICLIB
See searches and references containing RIBOCICLIB!RIBOCICLIB
Chemical compound
Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor
Ribociclib
Any chemical that inhibits the function of CDKs
FDA approved, but several compounds are in clinical trials. See also Ribociclib#Mechanism of action re: CDK4 The cell cycle is a highly regulated process
CDK_inhibitor
Investigational radiopharmaceutical
activity, while a phase Ib trial explores its use in combination with ribociclib and fulvestrant for estrogen receptor-positive (ER+), human epidermal
Lutetium-177_NeoBOMB1
Medication for HR+ HER2– breast cancer
approved ribociclib, owned by Novartis, as a combination therapy with aromatase inhibitors for indications similar to those of palbociclib and ribociclib. Notably
Palbociclib
Class of enzymes
metastatic breast cancer, often in combination with endocrine therapy. Ribociclib, demonstrating similar efficacy to palbociclib, is also approved for HR+/HER2-
Cyclin-dependent_kinase
Anti-breast cancer medication
shown in a study with rifampicin. Like the related drugs palbociclib and ribociclib, abemaciclib inhibits the enzymes cyclin-dependent kinase 4 (CDK4) and
Abemaciclib
Pharmaceutical drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Fuzuloparib
PARP inhibitor anti-cancer drug compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Pamiparib
Cancer that originates in mammary glands
fulvestrant, often used in combination with CDK4/6 inhibitors (palbociclib, ribociclib, or abemaciclib). When one endocrine therapy fails, most will benefit
Breast_cancer
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Dordaviprone
Experimental cancer drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Divarasib
Combination medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Niraparib/abiraterone_acetate
Drug Manufacturer Indication Letrozole/ribociclib Novartis Pharmaceuticals HR-positive, HER2-negative advanced or metastatic breast cancer Esketamine Janssen
List of drugs granted breakthrough therapy designation
List_of_drugs_granted_breakthrough_therapy_designation
Chemotherapy and immunosuppressant medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Methotrexate
Medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Tretinoin
Systematic naming of drugs
vandetanib -ciclib Cyclin-dependent kinase 4/CDK6 inhibitors palbociclib, ribociclib -degib hedgehog signaling pathway inhibitors vismodegib, sonidegib -denib
Drug_nomenclature
Chemotherapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Fluorouracil
Chemical compound
versus fulvestrant, both combined with a CDK4/6 inhibitor (palbociclib, ribociclib, or abemaciclib), in patients with ER+, HER2-negative advanced breast
Giredestrant
Chemotherapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Doxorubicin
Events leading to cell division
for anti-tumor effectiveness. Three Cdk4/6 inhibitors – palbociclib, ribociclib, and abemaciclib – currently received FDA approval for clinical use to
Cell_cycle
Industrial chemical and medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Arsenic_trioxide
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
4-Hydroxycyclophosphamide
Pharmaceutical drug classification
L01EE05 Mirdametinib L01EE06 Tunlametinib L01EF01 Palbociclib L01EF02 Ribociclib L01EF03 Abemaciclib L01EG01 Temsirolimus L01EG02 Everolimus L01EG03 Ridaforolimus
ATC_code_L01
Cancer medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Irinotecan
Chemical compound and pharmaceutical drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Cisplatin
Enzyme that metabolizes substances by oxidation
hypertension and chronic angina pectoris) nefazodone (antidepressant) ribociclib tucatinib chloramphenicol (antibiotic) some azole antifungals: ketoconazole
CYP3A4
Nonsteroidal anti-inflammatory medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Celecoxib
Medication used as chemotherapy and to suppress the immune system
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Cyclophosphamide
Human protein
sparking interest in the development of small-molecule inhibitors of CDK4/6. Ribociclib are US FDA approved CDK4 and CDK6 inhibitors for the treatment of estrogen
Cyclin-dependent_kinase_4
Regimen commonly used in chemotherapy
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Chemotherapy_regimen
Cancer medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Temozolomide
Medication used to treat cancer
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Carboplatin
Cancer drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Protein-bound_paclitaxel
Multi-protein structure
inhibitors have been approved or are in late-stage development: palbociclib, ribociclib, and abemaciclib. All three of these inhibitors are ATP-competitive, orally
Cyclin_D/Cdk4
Medication used for cancer
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Paclitaxel
Family of chemical compounds
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Nitrogen_mustard
Drugs that are useful against cancer
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
List of chemotherapeutic agents
List_of_chemotherapeutic_agents
Chemotherapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Ifosfamide
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Phenanthriplatin
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Gemcitabine
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Mitomycin_C
Chemical compound; chemotherapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Vincristine
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Bortezomib
PMC 5571795. PMID 28875019. Tripathy D, Bardia A, Sellers WR (July 2017). "Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent
Protein_crystallization
UK pharmaceutical company
biopharma partners into clinical trials and onto the market, including ribociclib (brand name “Kisqali”), a CDK4/CDK6 inhibitor discovered in collaboration
Astex_Pharmaceuticals
Medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Venetoclax
Chemotherapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Etoposide
Pharmaceutical drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Oxaliplatin
Chemical compound (chemotherapy medication)
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Cytarabine
Compounds that inhibit the activity of DNA topoisomerases
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Topoisomerase_inhibitor
Glycopeptide antibiotic used to treat various cancers
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Bleomycin
Medical condition
and CDK6). Other experimental CDK4/6 inhibitors include abemaciclib and ribociclib. Cancer stem cells (or cancer-initiating cells) are thought to be a small
Epithelioid_sarcoma
Chemical compound (cancer therapy drug)
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Olaparib
Cancer drug being studied
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Dibrospidium_chloride
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Capecitabine
Anti-cancer medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Niraparib
Type of spreading cancer
cells from growing and dividing. CDK4/6 inhibitors like palbociclib, ribociclib, abemaciclib, dalpiciclib, and trilaciclib are used to treat HR+/HER-
Metastatic_breast_cancer
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Navitoclax
Chemotherapy regimen for colorectal cancer treatment
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
FOLFIRI
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Talazoparib
Gene therapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Lisocabtagene_maraleucel
Gene therapy medication used to treat multiple myeloma
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Ciltacabtagene_autoleucel
Enzyme used as medication and in food manufacturing
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Asparaginase
Pharmaceutical drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Tebentafusp
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Azacitidine
Pharmaceutical drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Cladribine
Chemotherapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Docetaxel
Endogenous non-proteinogenic amino acid
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Aminolevulinic_acid
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Mercaptopurine
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Tiazofurin
Swiss multinational pharmaceutical corporation
Jakavi/Jakafi (ruxolitinib) Myelofibrosis (of intermediate to high risk) Kisqali (ribociclib) Breast Cancer 1,231 2022 Kymriah (tisagenlecleucel) Acute lymphoblastic
Novartis
Anti-cancer medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Vorasidenib
Chemotherapeutic agents used to treat cancer
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Platinum-based_antineoplastic
Pharmaceutical drugs
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Alkylating antineoplastic agent
Alkylating_antineoplastic_agent
Class of drugs used to treat malignant tumors
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Antineoplastic
Gene therapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Nadofaragene_firadenovec
Artificial stimulation of the immune system to treat cancer
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Cancer_immunotherapy
Tumor originating in adipose (fat) tissue
Research through Collaboration in collaboration with Eli Lilly and Company. Ribociclib, also a CDK4 and CDK6 gene inhibitor, in combination with a mTOR inhibitor
Liposarcoma
Mammalian protein found in humans
small molecule CDK4/6 inhibitors (palbociclib (Ibrance, Pfizer 2015), ribociclib (Kisqali, Novartis 2017), and abemaciclib (Verzenio, Eli Lilly 2017) for
Retinoblastoma_protein
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Belzutifan
Pharmaceutical drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Pegaspargase
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Sotorasib
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Cabazitaxel
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Omacetaxine_mepesuccinate
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Tazemetostat
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Busulfan
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Epacadostat
Medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Hydroxycarbamide
Gene therapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Idecabtagene_vicleucel
Pharmaceutical medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Calaspargase_pegol
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Chlormethine
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Taxane
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Carfilzomib
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Camptothecin
Chemotherapy medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Vinblastine
Medication
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Decitabine/cedazuridine
Chemical that inhibits the use of a metabolite
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Antimetabolite
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Dactinomycin
Chemical compound
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Carboquone
Pharmaceutical drug
inhibitors FI (Tipifarnib§) CDK inhibitors (Abemaciclib Alvocidib† Palbociclib Ribociclib Seliciclib†) PrI Bortezomib# Carfilzomib Oprozomib Ixazomib PhI (Anagrelide)
Vorinostat
RIBOCICLIB
RIBOCICLIB
RIBOCICLIB
RIBOCICLIB
Surname or Lastname
English
English : perhaps a variant spelling of Weldon.German : perhaps a respelling of Welden, a habitational name from a place so named in Bavaria.Possibly an altered spelling of Dutch Welden, a habitational name from a place so named in East Flanders, Belgium.
Boy/Male
Indian, Sanskrit
The Oblation Eater
Boy/Male
Indian, Sanskrit
Desirable; Charming
Boy/Male
Muslim
Radiant
Girl/Female
Sikh
Beautiful
Girl/Female
Latin
Majestic.
Girl/Female
Hindu
Beauty & goodness of the Moon
Boy/Male
Hindu, Indian
Lord Shiva
Male
Gaelic
Gaelic form of French Bernard, BEARNARD means "bold as a bear."
Boy/Male
Assamese, Hindu, Indian, Kannada, Sanskrit, Telugu
Teacher; Another Name for Drona
RIBOCICLIB
RIBOCICLIB
RIBOCICLIB
RIBOCICLIB
RIBOCICLIB